DRE and Prostate Cancer

Latest from the Blog

Meet the specialists: diagnosing ovarian cancer Q&A

Meet the specialists: diagnosing ovarian cancer Q&A

15th January 2021 Missed our free GatewayC webinar on Diagnosing Ovarian Cancer? Watch our recording here. In this webinar, GatewayC met Professor Gordon Jayson, Professor of Medical Oncology at The Christie NHS Foundation Trust, who answered key questions from our...

read more

Related Posts

Meet the specialists: diagnosing ovarian cancer Q&A

Meet the specialists: diagnosing ovarian cancer Q&A

15th January 2021 Missed our free GatewayC webinar on Diagnosing Ovarian Cancer? Watch our recording here. In this webinar, GatewayC met Professor Gordon Jayson, Professor of Medical Oncology at The Christie NHS Foundation Trust, who answered key questions from our...

read more

Friday 27th March 2020

A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA; and so a PSA alone may be falsely reassuring. Thus, a DRE can form an important part of the prostate cancer investigation process.

The examination:

All practitioners should be able to perform a DRE, as the prostate is positioned close to the anal vert, therefore the length of fingers do not restrict the examination. During a DRE, practitioners should assess the prostate to see if it is significantly:

Jagged
Hard
Irregular, as opposed to smooth.

 

Find out more:

Access GatewayC’s course ‘Prostate Cancer – Responding to a PSA Screening Request’ and collect up to 2 hours of CPD here.

Access this BMJ learning module here

Keep up to date: Twitter | Facebook | LinkedIn